Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Jan;67(1):198–204.

Altered monocyte function in patients with benign breast disease.

A M Al-Sumidaie, S J Leinster, S A Jenkins
PMCID: PMC1542549  PMID: 3621673

Abstract

Monocyte migration, lysozyme production and phagocytosis was studied in 34 patients with fibroadenosis, 28 patients with fibroadenoma and 48 healthy female controls. In patients with fibroadenosis and fibroadenoma, monocyte migration and phagocytic activity were significantly reduced when compared to controls (P less than 0.001). Conversely, lysozyme production by monocytes from patients with benign breast disease was significantly higher than in controls (P less than 0.001). In 20 patients with benign breast disease, there was no significant difference in monocyte function before and 3 months after operation. The observed impairment of monocyte function in fibroadenosis and fibroadenoma would not appear to be the result of abnormal blood biochemistry or due to a direct serum inhibitor, but is probably related to an intrinsic cellular defect. Further studies are required to evaluate the significance of impaired monocyte function in the pathophysiology of benign breast disease.

Full text

PDF
198

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barroeta O., Nungaray L., López-Osuna M., Armendares S., Salamanca F., Kretschmer R. R. Defective monocyte chemotaxis in children with Down's syndrome. Pediatr Res. 1983 Apr;17(4):292–295. doi: 10.1203/00006450-198304000-00013. [DOI] [PubMed] [Google Scholar]
  2. Cannon G. B., Barsky S. H., Alford T. C., Jerome L. F., Tinley V., McCoy J. L., Dean J. H. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease. J Natl Cancer Inst. 1982 Jun;68(6):935–943. [PubMed] [Google Scholar]
  3. Fixa B., Komárková O., Procházková J. Serum lysozyme in inflammatory gastric and enteric diseases and in functional dyspepsia. Scand J Gastroenterol. 1983 May;18(3):349–352. doi: 10.3109/00365528309181605. [DOI] [PubMed] [Google Scholar]
  4. Gange R. W., Black M. M., Carrington P., McKerron R. Defective neutrophil migration in sarcoidosis. Lancet. 1977 Aug 20;2(8034):379–381. doi: 10.1016/s0140-6736(77)90306-3. [DOI] [PubMed] [Google Scholar]
  5. Hallett M. B., Campbell A. K. Two distinct mechanisms for stimulation of oxygen-radical production by polymorphonuclear leucocytes. Biochem J. 1983 Nov 15;216(2):459–465. doi: 10.1042/bj2160459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hausman M. S., Brosman S., Snyderman R., Mickey M. R., Fahey J. Defective monocyte function in patients with genitourinary carcinoma. J Natl Cancer Inst. 1975 Nov;55(5):1047–1054. doi: 10.1093/jnci/55.5.1047. [DOI] [PubMed] [Google Scholar]
  7. Hill H. R., Augustine N. H., Rallison M. L., Santos J. I. Defective monocyte chemotactic responses in diabetes mellitus. J Clin Immunol. 1983 Jan;3(1):70–77. doi: 10.1007/BF00919141. [DOI] [PubMed] [Google Scholar]
  8. La Vecchia C., Parazzini F., Franceschi S., Decarli A. Risk factors for benign breast disease and their relation with breast cancer risk. Pooled information from epidemiologic studies. Tumori. 1985 Apr 30;71(2):167–178. doi: 10.1177/030089168507100213. [DOI] [PubMed] [Google Scholar]
  9. Maggiore G., De Giacomo C., Marconi M., Sacchi F., Scotta M. S. Defective neutrophil motility in children with chronic liver disease. Am J Dis Child. 1983 Aug;137(8):768–770. doi: 10.1001/archpedi.1983.02140340048013. [DOI] [PubMed] [Google Scholar]
  10. McVie J. G., Logan E. C., Kay A. B. Monocyte function in cancer patients. Eur J Cancer. 1977 Apr-May;13(4-5):351–353. doi: 10.1016/0014-2964(77)90080-9. [DOI] [PubMed] [Google Scholar]
  11. Nielsen H., Bennedsen J., Larsen S. O., Rhodes J. M., Viskum K. Defective monocyte chemotaxis in pulmonary tuberculosis. Eur J Respir Dis. 1982 Mar;63(2):122–129. [PubMed] [Google Scholar]
  12. PARRY R. M., Jr, CHANDAN R. C., SHAHANI K. M. A RAPID AND SENSITIVE ASSAY OF MURAMIDASE. Proc Soc Exp Biol Med. 1965 Jun;119:384–386. doi: 10.3181/00379727-119-30188. [DOI] [PubMed] [Google Scholar]
  13. Perillie P. E., Khan K., Finch S. C. Serum lysozyme in pulmonary tuberculosis. Am J Med Sci. 1973 Apr;265(4):297–302. doi: 10.1097/00000441-197304000-00005. [DOI] [PubMed] [Google Scholar]
  14. Rea T. H., Taylor C. R. Serum and tissue lysozyme in leprosy. Infect Immun. 1977 Dec;18(3):847–856. doi: 10.1128/iai.18.3.847-856.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rhodes J. M., Jewell D. P. Motility of neutrophils and monocytes in Crohn's disease and ulcerative colitis. Gut. 1983 Jan;24(1):73–77. doi: 10.1136/gut.24.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Segal A. W., Loewi G. Neutrophil dysfunction in Crohn's disease. Lancet. 1976 Jul 31;2(7979):219–221. doi: 10.1016/s0140-6736(76)91024-2. [DOI] [PubMed] [Google Scholar]
  17. Snyderman R., Meadows L., Holder W., Wells S., Jr Abnormal monocyte chemotaxis in patients with breast cancer: evidence for a tumor-mediated effect. J Natl Cancer Inst. 1978 Apr;60(4):737–740. doi: 10.1093/jnci/60.4.737. [DOI] [PubMed] [Google Scholar]
  18. Tecoma E. S., Huey L. Y. Psychic distress and the immune response. Life Sci. 1985 May 13;36(19):1799–1812. doi: 10.1016/0024-3205(85)90152-3. [DOI] [PubMed] [Google Scholar]
  19. Velardi A., Spinozzi F., Rambotti P., Tabilio A., Losito A., Zampi I., Cernetti C., Martelli M. F., Grignani F., Davis S. The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients. J Clin Oncol. 1983 Feb;1(2):117–125. doi: 10.1200/JCO.1983.1.2.117. [DOI] [PubMed] [Google Scholar]
  20. Wandall J. H., Binder V. Leucocyte function in Crohn's disease. Studies on mobilisation using a quantitative skin window technique and on the function of circulating polymorphonuclear leucocytes in vitro. Gut. 1982 Mar;23(3):173–180. doi: 10.1136/gut.23.3.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yam L. T., Li C. Y., Crosby W. H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971 Mar;55(3):283–290. doi: 10.1093/ajcp/55.3.283. [DOI] [PubMed] [Google Scholar]
  22. Yamane T., Sakita M., Kasuga M., Nishioka B., Fujita Y., Majima S. Monocyte count, monocyte chemotaxis and chemotactic factor inactivator in gastric cancer patients. Jpn J Surg. 1981;11(6):422–427. doi: 10.1007/BF02469025. [DOI] [PubMed] [Google Scholar]
  23. Zorn S. K., Stevens C. A., Schachter E. N., Gee J. B. The angiotensin converting enzyme in pulmonary sarcoidosis and the relative diagnostic value of serum lysozyme. Lung. 1980;157(2):87–94. doi: 10.1007/BF02713601. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES